Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells

Malignant gliomas have a highly tumorigenic subpopulation, termed cancer stem cells (CSCs), that drives tumor formation and proliferation. CSCs possess inherent resistance mechanisms against radiation- and chemotherapy- induced cancer cell death, enabling them to survive and initiate tumor recurrenc...

Full description

Bibliographic Details
Main Authors: Warrier, S., Balu, S., Kumar, Alan Prem, Michael, M., Dharmarajan, Arunasalam
Format: Journal Article
Published: Cognizant Communication Corporation 2014
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/20326
_version_ 1848750274624094208
author Warrier, S.
Balu, S.
Kumar, Alan Prem
Michael, M.
Dharmarajan, Arunasalam
author_facet Warrier, S.
Balu, S.
Kumar, Alan Prem
Michael, M.
Dharmarajan, Arunasalam
author_sort Warrier, S.
building Curtin Institutional Repository
collection Online Access
description Malignant gliomas have a highly tumorigenic subpopulation, termed cancer stem cells (CSCs), that drives tumor formation and proliferation. CSCs possess inherent resistance mechanisms against radiation- and chemotherapy- induced cancer cell death, enabling them to survive and initiate tumor recurrence. We examined the effect of secreted frizzled-related protein 4 (sFRP4), a Wnt signaling antagonist, in chemosensitizing the glioma cell line U138MG and glioma stem cells (GSCs) enriched from U138MG to chemotherapeutics. We found that sFRP4 alone and in combination with either doxorubicin or cisplatin induced apoptosis. Proliferation decreased substantially in GSC-enriched population as measured by MTT and BrdU assays. JC-1 and caspase- 3 assays demonstrated that cell death was through the apoptotic pathway. sFRP4 treatment also decreased neurosphere formation and induced neuronal differentiation. Inhibition by sFRP4 was abolished by Wnt3a, indicating that sFRP4 acts through the frizzled receptor. Further indication that sFRP4 acts through the Wnt b-catenin pathway was provided by decrease in the b-catenin protein and decrease in the b-catenin-stimulatedgene cyclin D1 upon sFRP4 induction. By real-time PCR, an increase in apoptotic markers Bax and p21, a decrease in pro-proliferative marker CycD1, and a decrease in the GSC marker CD133 were observed. These observations indicate that sFRP4 is able to sensitize glioma cells and stem cells to chemotherapeutics. We thus identified for the first time that sFRP4 could help to destroy cancer stem cells of glioma cell line, which would lead to effective treatment regimen to combat brain tumors.
first_indexed 2025-11-14T07:34:14Z
format Journal Article
id curtin-20.500.11937-20326
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:34:14Z
publishDate 2014
publisher Cognizant Communication Corporation
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-203262017-09-13T13:49:38Z Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells Warrier, S. Balu, S. Kumar, Alan Prem Michael, M. Dharmarajan, Arunasalam Secreted frizzled-related protein 4 (sFRP4) Apoptosis Glioma stem cells (GSCs) Chemosensitivity Wnt antagonist Malignant gliomas have a highly tumorigenic subpopulation, termed cancer stem cells (CSCs), that drives tumor formation and proliferation. CSCs possess inherent resistance mechanisms against radiation- and chemotherapy- induced cancer cell death, enabling them to survive and initiate tumor recurrence. We examined the effect of secreted frizzled-related protein 4 (sFRP4), a Wnt signaling antagonist, in chemosensitizing the glioma cell line U138MG and glioma stem cells (GSCs) enriched from U138MG to chemotherapeutics. We found that sFRP4 alone and in combination with either doxorubicin or cisplatin induced apoptosis. Proliferation decreased substantially in GSC-enriched population as measured by MTT and BrdU assays. JC-1 and caspase- 3 assays demonstrated that cell death was through the apoptotic pathway. sFRP4 treatment also decreased neurosphere formation and induced neuronal differentiation. Inhibition by sFRP4 was abolished by Wnt3a, indicating that sFRP4 acts through the frizzled receptor. Further indication that sFRP4 acts through the Wnt b-catenin pathway was provided by decrease in the b-catenin protein and decrease in the b-catenin-stimulatedgene cyclin D1 upon sFRP4 induction. By real-time PCR, an increase in apoptotic markers Bax and p21, a decrease in pro-proliferative marker CycD1, and a decrease in the GSC marker CD133 were observed. These observations indicate that sFRP4 is able to sensitize glioma cells and stem cells to chemotherapeutics. We thus identified for the first time that sFRP4 could help to destroy cancer stem cells of glioma cell line, which would lead to effective treatment regimen to combat brain tumors. 2014 Journal Article http://hdl.handle.net/20.500.11937/20326 10.3727/096504013X13786659070154 Cognizant Communication Corporation fulltext
spellingShingle Secreted frizzled-related protein 4 (sFRP4)
Apoptosis
Glioma stem cells (GSCs)
Chemosensitivity Wnt antagonist
Warrier, S.
Balu, S.
Kumar, Alan Prem
Michael, M.
Dharmarajan, Arunasalam
Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
title Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
title_full Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
title_fullStr Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
title_full_unstemmed Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
title_short Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
title_sort wnt antagonist, secreted frizzled-related protein 4 (sfrp4), increases chemotherapeutic response of glioma stem-like cells
topic Secreted frizzled-related protein 4 (sFRP4)
Apoptosis
Glioma stem cells (GSCs)
Chemosensitivity Wnt antagonist
url http://hdl.handle.net/20.500.11937/20326